Overview

RSYR for Fatigue Reduction in Cancer Survivors

Status:
Completed
Trial end date:
2019-02-01
Target enrollment:
0
Participant gender:
All
Summary
This randomized Phase II trial to establish the efficacy of traditional Chinese medicine (TCM) herbal products above control group for treating fatigue in patients with cancer.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Beijing Cancer Hospital
Criteria
Inclusion Criteria:

Pathological diagnosis of malignant tumors; 3 months without surgery, radiotherapy and
chemotherapy, biological treatment; Hemoglobin > 11g/L; Complete remission of the lesion,
or recent review of the Disease is stable, the estimated survival time is more than 6
months; ECOG score is 0-2, fatigue score of the last 24 hours > 4 ; Age is 18-65 years old;
TCM syndrome differentiation for deficiency of qi; Liver, kidney function, electrolyte
normal; Willing to join the group and sign the informed consent.

Exclusion Criteria:

Allergies to herbs and plant drugs; Uncontrollable diabetes, hypertension, TSH
abnormalities, uncontrollable pain, and a history of myocardial infarction within 6 months;
Scores of anxiety disorders and depression (HAD-D) were 11 or more, antidepressants and
antioxidants were used in the past month; Breast cancer receptor positive patients took
endocrine therapy drugs; Tonics were used in the past 2 weeks.; Children, pregnant and
lactating women; Receiving anemia-related treatment; Chinese medicine syndrome
differentiation with excessive heat; Unable to read or understand the scale.